Rashti Womens Care 314 W Junipero St, Santa Barbara, CA 93105 (805)6827109 (phone), (805)6821719 (fax)
Education:
Medical School Univ of Cairo, Fac of Med, Cairo, Egypt (330 02 Prior 1/71) Graduated: 1978
Conditions:
Conditions of Pregnancy and Delivery Abnormal Vaginal Bleeding Breast Disorders Candidiasis of Vulva and Vagina Complicating Pregnancy or Childbirth
Languages:
English Spanish
Description:
Dr. Zaki graduated from the Univ of Cairo, Fac of Med, Cairo, Egypt (330 02 Prior 1/71) in 1978. He works in Santa Barbara, CA and specializes in Obstetrics & Gynecology. Dr. Zaki is affiliated with Goleta Valley Cottage Hospital and Santa Barbara Cottage Hospital.
Wikipedia References
Mohamed Zaki
About:
Born:
1953
Work:
Position:
Prime Minister • President
Skills & Activities:
Preference:
Democratic
Master status:
Working part time
Us Patents
Use Of Il-6 Antagonists In Combination With Steroids To Enhance Apoptosis
Mohit Trikha - Malvern PA, US Mohamed Zaki - Audubon PA, US
International Classification:
A61K039/395 A61K031/573
US Classification:
424/145100, 514/171000
Abstract:
Methods for the use of antibodies directed toward IL-6, including specified portions or variants, specific for at least one Interleukin-6 (IL-6 also known as interferon 2)) protein or fragment thereof, in combination with steroids for the treatment of proliferative diseases such as cancer which are amenable to treatment by apoptosis inducing agents.
Assay Method To Monitor The Response Of Anti-Cytokine Therapy
Mohamed Zaki - Audubon PA, US Suzanne Mount - Ridley Park PA, US Mohit Trikha - Paoli PA, US Jeffrey Nemeth - Havertown PA, US
International Classification:
G01N033/53 A61K039/395 G01N033/567
US Classification:
424145100, 435007200
Abstract:
A method of monitoring the response to anti-cytokine therapy in a patient undergoing such therapy by using Serum Amyloid A (SAA) protein as a biomarker.
Mohamed Zaki - Audubon PA, US Christian Jacques - Hamburg NJ, US
Assignee:
CELGENE CORPORATION - Summit NJ
International Classification:
G01N 33/68
US Classification:
435 29
Abstract:
Provided herein are the biomarkers for predicting or monitoring the efficacy of a treatment for multiple myeloma. The use of certain M-protein or other protein levels as biomarkers to predict whether a multiple myeloma treatment is likely to be successful is also provided. Further, the analysis of these biomarkers can be used to monitor progress of treatment effectiveness and patient compliance in multiple myeloma patients who are receiving treatment.
Youtube
MAXAMED ZAKI - INAAN KU ARKAA QORNAYDE OFFICI...
MAXAMED ZAKI INAAN KU ARKAA QORNAYDE Eraydi Goomeey Lacan& Music Samii...
Duration:
6m 2s
AHMED ZAKI | Koolkooliso | (2017)
HAATAF ABDI Please don't forget to subscribe.
Duration:
5m 37s
Existence is Pain | Mohamed Zaki | TEDxYouth@...
Pain is something we've all experienced, with different degrees and di...
stracted. To avoid oncoming vehicles, they reduced their speeds by adjusting their step frequency, while non-distracted pedestrians adjusted both their step frequency and the length of their steps, said study co-author Mohamed Zaki, a research associate in the department of civil engineering at UBC.